Science says teens need more sleep. So why is it so hard to start school later?

No­var­tis un­veiled pos­i­tive reg­is­tra­tional da­ta for its BTK in­hibitor can­di­date in chron­ic spon­ta­neous ur­ticaria, trig­ger­ing plans for reg­u­la­to­ry fil­ings. But strong Phase II read­out from

Pa­trizia Cavaz­zoni, the FDA’s for­mer head of drug reg­u­la­tion, will be­come Pfiz­er’s new chief med­ical of­fi­cer, End­points News has learned. Cavaz­zoni led the FDA’s Cen­ter